Douglass Winthrop Advisors LLC increased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,687 shares of the company’s stock after buying an additional 300 shares during the quarter. Douglass Winthrop […]